Skip to main content
Equibles

MORGAN STANLEY

Position in XGN — Exagen Inc.

CIK 895421 NEW YORK, NY
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$29,471
-$7,180 QoQ
Shares Held
6,338
-48.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 57 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $13,614,781,147 across 42 Diagnostics & Research names. XGN ranks #33 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 10,763,066 $5,396,170,760
2 DHR
Danaher Corp /De/
 11,348,958 $2,161,749,507
3 IDXX
Idexx Laboratories Inc /De
 1,356,103 $713,906,852
4 A
Agilent Technologies, Inc.
 5,185,738 $688,821,571
5 MTD
Mettler Toledo International Inc/
 465,226 $594,330,857
6 IQV
Iqvia Holdings Inc.
 2,707,252 $523,095,221
7 DGX
Quest Diagnostics Inc
 2,460,497 $521,502,333
8 LH
Labcorp Holdings Inc.
 1,609,447 $450,645,160

All Filings in XGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,471 6,338
2026-03-31 $36,651 12,217
2025-12-31 $592,422 97,438
2025-09-30 $473,415 43,077
2025-06-30 $3,664,472 524,996
2025-03-31 $1,744,452 485,920
2024-12-31 $1,983,252 483,720
2024-09-30 $1,490,677 482,420
2024-06-30 $878,004 482,420
2024-03-31 $767,047 482,420
2023-12-31 $963,000 483,920
2023-09-30 $1,164,020 481,000
2023-06-30 $1,394,900 481,000
2023-03-31 $1,169,004 481,072
2022-12-31 $1,163,858 484,941
2022-09-30 $1,337,779 493,646
2022-06-30 $2,863,488 498,866
2022-03-31 $4,292,603 534,571
2021-12-31 $6,095,583 524,126
2021-09-30 $6,780,781 498,587
2021-06-30 $5,469,310 364,864
2021-03-31 $1,730,102 98,863
2020-12-31 $104,029 7,881
2020-09-30 $107,748 9,940
2020-06-30 $38,122 3,072
2020-03-31 $15,923 999